Robigo raises an undisclosed amount series a
Announced 17 September 2026
◆ The Round
Robigo raised an undisclosed amount in series a funding, announced on 17 September 2026, led by Leaps by Bayer, with participation from Illumina Ventures, SVG Thrive, Congruent Ventures, Endeavor8. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About Robigo
Biotechnology company engineering biological solutions for crop protection using synthetic biology and its proprietary ARGO platform. Robigo is based in United States and currently at series a stage, operating in Agtech, Biotech.
◆ Investors
LeadLeaps by Bayer
ParticipationIllumina Ventures, SVG Thrive, Congruent Ventures, Endeavor8
◆ Market context
This funding event is a citable node in Fusion42's market graph: it links Robigo's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did Robigo raise?
Robigo raised an undisclosed amount in its series-a round, announced 2026-09-17.
Who invested in Robigo's series-a round?
The round was led by Leaps by Bayer, with participation from Illumina Ventures, SVG Thrive, Congruent Ventures and Endeavor8.
What does Robigo do?
Biotechnology company engineering biological solutions for crop protection using synthetic biology and its proprietary ARGO platform.
Verified 17 September 2026 · Sources: public filings